Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Total Liabilities (2021 - 2025)

Biote (BTMD) has 5 years of Total Liabilities data on record, last reported at $176.8 million in Q3 2025.

  • For Q3 2025, Total Liabilities fell 22.49% year-over-year to $176.8 million; the TTM value through Sep 2025 reached $176.8 million, down 22.49%, while the annual FY2024 figure was $224.6 million, 17.06% up from the prior year.
  • Total Liabilities reached $176.8 million in Q3 2025 per BTMD's latest filing, down from $183.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $324.9 million in Q2 2021 and bottomed at $21.8 million in Q1 2022.
  • Average Total Liabilities over 5 years is $171.8 million, with a median of $191.8 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: plummeted 44.41% in 2022, then skyrocketed 832.36% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $50.2 million in 2021, then surged by 238.45% to $169.9 million in 2022, then grew by 12.9% to $191.8 million in 2023, then rose by 17.06% to $224.6 million in 2024, then fell by 21.28% to $176.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $176.8 million in Q3 2025, $183.6 million in Q2 2025, and $208.2 million in Q1 2025.